Sputnik V COVID-19 vaccine
Sputnik V COVID-19 Vaccine
The Sputnik V COVID-19 Vaccine (pronounced "Sputnik Five") is a vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Russia for the prevention of COVID-19.
Etymology
The name "Sputnik V" is derived from the Russian word "Спутник", which translates to "satellite" in English. The "V" stands for "vaccine". The name is a reference to the Sputnik 1, the first artificial Earth satellite launched by the Soviet Union in 1957, symbolizing the country's pioneering role in space exploration.
Description
Sputnik V is a viral vector vaccine that uses a modified version of the adenovirus, a common cold virus, to deliver a piece of the SARS-CoV-2 virus's genetic material into cells in the body. This triggers an immune response that helps protect against COVID-19.
Efficacy
According to the interim results of the phase III clinical trial published in The Lancet, Sputnik V has an efficacy rate of 91.6% against symptomatic COVID-19.
Related Terms
- Vaccine
- COVID-19
- SARS-CoV-2
- Gamaleya Research Institute of Epidemiology and Microbiology
- The Lancet
- Viral vector vaccine
- Adenovirus
- Phase III clinical trial
External links
- Medical encyclopedia article on Sputnik V COVID-19 vaccine
- Wikipedia's article - Sputnik V COVID-19 vaccine
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski